Literature DB >> 15958529

Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.

Michael Uhlin1, Maria G Masucci, Victor Levitsky.   

Abstract

After specific activation, CD8+ cytotoxic T lymphocytes (CTLs) enter a refractory state termed activation-induced nonresponsiveness (AINR) that is characterized by the inability of T cells to respond to a secondary stimulus. Here, we show that T cell receptor triggering results in rapid degradation of the src-family protein kinase lck through a mechanism that is proteasome- and lysosome-independent, sensitive to cysteine protease inhibitors, and distinct from the pathways involved in degradation of ZAP-70 kinase or zeta-chain of the CD3 complex. Pharmacologic blockade of lck degradation, as well as transfection of refractory cells with an lck expression vector, increased responsiveness of CTLs to repeated antigenic challenge. The development or maintenance of AINR was not affected by exogenously added IL-2, whereas IL-15 or IFN-alpha restored both lck expression and responsiveness of preactivated CTLs. Our results suggest that lck degradation plays an important role in the development of AINR in human CTLs and that this condition can be reverted by pharmacologic agents or lymphokines that prevent lck degradation or induce its expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958529      PMCID: PMC1166584          DOI: 10.1073/pnas.0406333102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).

Authors:  Ee Loon Tham; Matthew F Mescher
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

3.  Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells.

Authors:  Lorri A Morford; Kathy Forrest; Barbara Logan; L Kevin Overstreet; Jens Goebel; William H Brooks; Thomas L Roszman
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

4.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

5.  Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.

Authors:  Elena Sandalova; Cheng-Hong Wei; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

6.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.

Authors:  Mayumi Naramura; Ihn-Kyung Jang; Hemanta Kole; Fang Huang; Diana Haines; Hua Gu
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

Review 7.  The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation.

Authors:  Rose Zamoyska; Albert Basson; Andrew Filby; Giuseppe Legname; Matthew Lovatt; Benedict Seddon
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

8.  Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15.

Authors:  Vivek Chitnis; Rajendra Pahwa; Savita Pahwa
Journal:  Clin Immunol       Date:  2003-04       Impact factor: 3.969

9.  Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation.

Authors:  Cheng-Hong Wei; Michael Uhlin; Maria G Masucci; Victor Levitsky
Journal:  Hum Immunol       Date:  2002-10       Impact factor: 2.850

10.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation.

Authors:  Kaisa Haglund; Sara Sigismund; Simona Polo; Iwona Szymkiewicz; Pier Paolo Di Fiore; Ivan Dikic
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

View more
  6 in total

Review 1.  Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.

Authors:  Matthew F Mescher; Pujya Agarwal; Kerry A Casey; Christopher D Hammerbeck; Zhengguo Xiao; Julie M Curtsinger
Journal:  Semin Immunol       Date:  2007-03-26       Impact factor: 11.130

2.  Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Authors:  J Gertow; S Berglund; M Okas; M Uzunel; L Berg; K Kärre; J Mattsson; M Uhlin
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

Review 3.  Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.

Authors:  Matthew F Mescher; Flavia E Popescu; Michael Gerner; Chris D Hammerbeck; Julie M Curtsinger
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

4.  Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Authors:  Arwen Stikvoort; Mikael Sundin; Mehmet Uzunel; Jens Gertow; Berit Sundberg; Marie Schaffer; Jonas Mattsson; Michael Uhlin
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

5.  Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility.

Authors:  Sofia Berglund; Ahmed Gaballa; Piamsiri Sawaisorn; Berit Sundberg; Michael Uhlin
Journal:  Stem Cells Int       Date:  2018-03-07       Impact factor: 5.443

6.  Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Authors:  Arwen Stikvoort; Yang Chen; Emelie Rådestad; Johan Törlén; Tadepally Lakshmikanth; Andreas Björklund; Jaromir Mikes; Adnane Achour; Jens Gertow; Berit Sundberg; Mats Remberger; Mikael Sundin; Jonas Mattsson; Petter Brodin; Michael Uhlin
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.